MALVERN, PA — LifeScan recently appointed Jonathan Salkin chief executive officer effective immediately, ending a months-long interim leadership structure as the diabetes monitoring company seeks to expand its position in the global glucose management market.
Salkin succeeds co-interim CEOs Michael Hooks and James Rushing, who have led the company since January 2026. Hooks will remain chairman of the board, while Rushing will continue as executive vice president and chief financial officer.
The leadership change places a medical technology executive with experience in healthcare and laboratory businesses at the helm of LifeScan, whose OneTouch brand serves more than 20 million diabetes patients worldwide.
Salkin most recently served as chief executive officer of Antylia Scientific, where he oversaw the company’s transition from a laboratory distribution business into a broader life sciences and bioprocessing platform. Earlier in his career, he held senior leadership roles at Devicor Medical Products and Cardinal Health.
Hooks described Salkin as the outcome of an extensive executive search and pointed to his experience leading healthcare and medical technology companies through operational and strategic transitions.
“I’m proud to join LifeScan, a company that has earned the confidence of the diabetes community for more than 40 years,” Salkin said. “That level of trust carries a meaningful responsibility to continue delivering reliable solutions that improve outcomes for patients and caregivers.”
LifeScan develops blood glucose monitoring systems and diabetes management tools for consumers and healthcare providers. The company’s OneTouch products remain among the best-known brands in glucose monitoring as diabetes care companies compete to expand digital health and patient management offerings.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.